Concepts (134)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetic Resonance Imaging | 34 | 2023 | 468 | 10.220 |
Why?
|
| Nephrons | 14 | 2022 | 22 | 6.950 |
Why?
|
| Kidney Glomerulus | 17 | 2023 | 80 | 6.250 |
Why?
|
| Ferritins | 14 | 2023 | 54 | 4.990 |
Why?
|
| Kidney Diseases | 10 | 2022 | 159 | 4.610 |
Why?
|
| Kidney | 19 | 2023 | 322 | 4.460 |
Why?
|
| Contrast Media | 13 | 2021 | 95 | 3.100 |
Why?
|
| Renal Insufficiency, Chronic | 5 | 2023 | 160 | 2.090 |
Why?
|
| Image Processing, Computer-Assisted | 7 | 2021 | 164 | 2.050 |
Why?
|
| Imaging, Three-Dimensional | 4 | 2020 | 89 | 1.910 |
Why?
|
| Nanoparticles | 5 | 2016 | 294 | 1.450 |
Why?
|
| Animals | 36 | 2023 | 14307 | 1.440 |
Why?
|
| Image Enhancement | 5 | 2021 | 41 | 1.130 |
Why?
|
| Glomerular Filtration Rate | 6 | 2022 | 137 | 1.090 |
Why?
|
| Rats | 15 | 2022 | 3261 | 0.980 |
Why?
|
| Gadolinium | 1 | 2022 | 27 | 0.880 |
Why?
|
| Mice | 12 | 2023 | 5668 | 0.870 |
Why?
|
| Rats, Sprague-Dawley | 12 | 2021 | 1534 | 0.840 |
Why?
|
| Kidney Tubules | 1 | 2021 | 28 | 0.780 |
Why?
|
| Disease Models, Animal | 5 | 2020 | 1300 | 0.770 |
Why?
|
| Escherichia coli | 1 | 2023 | 436 | 0.730 |
Why?
|
| Syndactyly | 1 | 2019 | 1 | 0.720 |
Why?
|
| Brain | 2 | 2021 | 1268 | 0.710 |
Why?
|
| Computer Simulation | 1 | 2021 | 347 | 0.670 |
Why?
|
| Male | 18 | 2023 | 18870 | 0.660 |
Why?
|
| Drug Delivery Systems | 3 | 2014 | 182 | 0.610 |
Why?
|
| Humans | 23 | 2022 | 34853 | 0.610 |
Why?
|
| Algorithms | 5 | 2021 | 435 | 0.610 |
Why?
|
| Ferric Compounds | 2 | 2014 | 49 | 0.570 |
Why?
|
| Organ Size | 4 | 2021 | 148 | 0.550 |
Why?
|
| Liver | 2 | 2016 | 447 | 0.510 |
Why?
|
| Diagnostic Imaging | 1 | 2015 | 53 | 0.510 |
Why?
|
| Cations | 4 | 2019 | 44 | 0.490 |
Why?
|
| Cell Count | 1 | 2014 | 129 | 0.480 |
Why?
|
| Iron | 2 | 2016 | 204 | 0.470 |
Why?
|
| Extracellular Matrix | 1 | 2013 | 111 | 0.450 |
Why?
|
| Metal Nanoparticles | 1 | 2016 | 180 | 0.450 |
Why?
|
| Reproducibility of Results | 4 | 2021 | 901 | 0.450 |
Why?
|
| Magnetics | 1 | 2012 | 36 | 0.430 |
Why?
|
| Nanomedicine | 1 | 2012 | 32 | 0.420 |
Why?
|
| Positron-Emission Tomography | 2 | 2023 | 79 | 0.410 |
Why?
|
| Apoferritins | 1 | 2010 | 5 | 0.390 |
Why?
|
| Enzyme Precursors | 1 | 2010 | 10 | 0.390 |
Why?
|
| Gentamicins | 2 | 2020 | 9 | 0.380 |
Why?
|
| Nanostructures | 1 | 2012 | 133 | 0.370 |
Why?
|
| Indomethacin | 2 | 2020 | 24 | 0.370 |
Why?
|
| Hydrogels | 1 | 2010 | 33 | 0.370 |
Why?
|
| Horses | 2 | 2023 | 24 | 0.370 |
Why?
|
| Mice, Inbred C57BL | 3 | 2021 | 1530 | 0.370 |
Why?
|
| Rabbits | 2 | 2020 | 278 | 0.360 |
Why?
|
| Oxides | 1 | 2010 | 89 | 0.360 |
Why?
|
| Animals, Newborn | 2 | 2020 | 323 | 0.340 |
Why?
|
| Basement Membrane | 1 | 2008 | 28 | 0.340 |
Why?
|
| Genes, Reporter | 1 | 2008 | 132 | 0.320 |
Why?
|
| Renal Circulation | 2 | 2021 | 18 | 0.250 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2023 | 22 | 0.230 |
Why?
|
| Aged | 3 | 2021 | 6448 | 0.230 |
Why?
|
| Chemokine CX3CL1 | 1 | 2023 | 13 | 0.230 |
Why?
|
| Software | 3 | 2021 | 204 | 0.230 |
Why?
|
| Biopsy, Needle | 1 | 2021 | 60 | 0.210 |
Why?
|
| Normal Distribution | 1 | 2021 | 15 | 0.210 |
Why?
|
| Urinary Tract | 1 | 2021 | 7 | 0.210 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2021 | 18 | 0.200 |
Why?
|
| Copper Radioisotopes | 1 | 2020 | 8 | 0.200 |
Why?
|
| Monte Carlo Method | 1 | 2021 | 55 | 0.200 |
Why?
|
| Premature Birth | 1 | 2021 | 71 | 0.190 |
Why?
|
| Tissue Donors | 1 | 2020 | 43 | 0.190 |
Why?
|
| Kidney Transplantation | 1 | 2020 | 85 | 0.180 |
Why?
|
| Sensitivity and Specificity | 2 | 2013 | 555 | 0.180 |
Why?
|
| Female | 6 | 2021 | 19873 | 0.170 |
Why?
|
| Cell Differentiation | 1 | 2021 | 562 | 0.170 |
Why?
|
| Genetic Variation | 1 | 2020 | 328 | 0.160 |
Why?
|
| Cohort Studies | 1 | 2021 | 1422 | 0.160 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2020 | 528 | 0.150 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2017 | 67 | 0.150 |
Why?
|
| Disease Progression | 1 | 2019 | 580 | 0.150 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 424 | 0.140 |
Why?
|
| Pattern Recognition, Automated | 1 | 2016 | 30 | 0.140 |
Why?
|
| Middle Aged | 3 | 2021 | 9642 | 0.140 |
Why?
|
| Histology | 1 | 2015 | 1 | 0.130 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 2333 | 0.130 |
Why?
|
| Pathology | 1 | 2015 | 7 | 0.130 |
Why?
|
| Adult | 3 | 2021 | 11034 | 0.130 |
Why?
|
| Young Adult | 2 | 2021 | 4012 | 0.130 |
Why?
|
| Artificial Intelligence | 1 | 2015 | 63 | 0.130 |
Why?
|
| Cluster Analysis | 1 | 2015 | 188 | 0.130 |
Why?
|
| Molecular Probe Techniques | 1 | 2013 | 7 | 0.120 |
Why?
|
| Models, Statistical | 1 | 2015 | 171 | 0.120 |
Why?
|
| Molecular Probes | 1 | 2013 | 23 | 0.120 |
Why?
|
| Nanotechnology | 1 | 2014 | 150 | 0.110 |
Why?
|
| Phantoms, Imaging | 2 | 2013 | 22 | 0.110 |
Why?
|
| Metabolic Clearance Rate | 1 | 2012 | 22 | 0.110 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2012 | 3 | 0.110 |
Why?
|
| Injections, Intravenous | 1 | 2012 | 58 | 0.110 |
Why?
|
| Organ Specificity | 1 | 2012 | 123 | 0.110 |
Why?
|
| Tissue Distribution | 1 | 2012 | 197 | 0.100 |
Why?
|
| Perfusion | 2 | 2021 | 31 | 0.100 |
Why?
|
| Monitoring, Physiologic | 2 | 2021 | 35 | 0.100 |
Why?
|
| Enteropeptidase | 1 | 2010 | 1 | 0.100 |
Why?
|
| Trypsinogen | 1 | 2010 | 1 | 0.100 |
Why?
|
| Macromolecular Substances | 1 | 2010 | 86 | 0.090 |
Why?
|
| Proteoglycans | 1 | 2010 | 46 | 0.090 |
Why?
|
| Tissue Engineering | 1 | 2010 | 59 | 0.090 |
Why?
|
| Biocompatible Materials | 1 | 2010 | 75 | 0.090 |
Why?
|
| Linear Models | 1 | 2010 | 253 | 0.090 |
Why?
|
| Manganese | 1 | 2010 | 59 | 0.090 |
Why?
|
| Polymers | 1 | 2010 | 117 | 0.090 |
Why?
|
| Spinal Cord Injuries | 1 | 2010 | 60 | 0.090 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2008 | 185 | 0.080 |
Why?
|
| Child, Preschool | 2 | 2020 | 1318 | 0.070 |
Why?
|
| Organogenesis | 1 | 2021 | 16 | 0.050 |
Why?
|
| Morphogenesis | 1 | 2021 | 48 | 0.050 |
Why?
|
| Child | 2 | 2020 | 2875 | 0.050 |
Why?
|
| Models, Animal | 1 | 2021 | 131 | 0.050 |
Why?
|
| Gene Regulatory Networks | 1 | 2021 | 115 | 0.050 |
Why?
|
| Stem Cells | 1 | 2021 | 132 | 0.050 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2021 | 283 | 0.040 |
Why?
|
| Gene Expression | 1 | 2021 | 639 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2021 | 296 | 0.040 |
Why?
|
| Critical Illness | 1 | 2018 | 37 | 0.040 |
Why?
|
| Mice, Knockout | 1 | 2020 | 897 | 0.040 |
Why?
|
| Transcription Factors | 1 | 2021 | 653 | 0.040 |
Why?
|
| Pregnancy | 1 | 2021 | 1503 | 0.040 |
Why?
|
| Prognosis | 1 | 2018 | 707 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2018 | 871 | 0.030 |
Why?
|
| Infant | 1 | 2018 | 1014 | 0.030 |
Why?
|
| Gadolinium DTPA | 1 | 2013 | 18 | 0.030 |
Why?
|
| Equipment Design | 1 | 2013 | 127 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2013 | 196 | 0.030 |
Why?
|
| Manganese Compounds | 1 | 2010 | 12 | 0.020 |
Why?
|
| Adolescent | 1 | 2020 | 5035 | 0.020 |
Why?
|
| Chlorides | 1 | 2010 | 52 | 0.020 |
Why?
|
| Risk Factors | 1 | 2018 | 3414 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2010 | 255 | 0.020 |
Why?
|